Literature DB >> 4063232

Distribution of placental protein 14 in tissues and body fluids during pregnancy.

M Julkunen, E M Rutanen, A Koskimies, T Ranta, H Bohn, M Seppälä.   

Abstract

Placental protein 14 (PP14) levels were measured in serum samples from non-pregnant and pregnant women, amniotic fluid, cord blood, and extracts of placenta, decidua and fetal membranes. The levels were low (15-40 micrograms/l) in serum of non-pregnant women. In four pregnancies following in-vitro fertilization, the serum PP14 levels started to rise 2-12 days after embryo replacement. In normal pregnancy, the highest serum PP14 concentrations (up to 2200 micrograms/l) were detected between 6 and 12 weeks. After 16 weeks the level decreased and plateaued at 24 weeks to around 200 micrograms/l. In amniotic fluid, the highest PP14 levels (232 mg/l) were found between 12 and 20 weeks, being considerably higher than those in maternal serum throughout pregnancy. In cord blood, the levels were low (15-22 micrograms/l) or undetectable. In early pregnancy decidua, the PP14 content was higher (41-160 mg/g total protein) than in late pregnancy decidua (60-2700 micrograms/g total protein). In amnion and chorion laeve, the PP14 concentration varied from 50 to 750 and 50 to 1000 micrograms/g protein, respectively. Early pregnancy placenta contained 0.25-15 mg/g and late pregnancy placenta 3-430 micrograms/g protein of PP14. These results show that the levels of PP14 in pregnancy serum have a similar profile to hCG, but in contrast to other placental proteins, the amniotic fluid PP14 levels are remarkably high. This may be explained by suggesting that decidua is a source of PP14.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4063232     DOI: 10.1111/j.1471-0528.1985.tb03027.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  32 in total

1.  Characterization of the transcriptome of chorioamniotic membranes at the site of rupture in spontaneous labor at term.

Authors:  Chia-Ling Nhan-Chang; Roberto Romero; Adi L Tarca; Pooja Mittal; Juan Pedro Kusanovic; Offer Erez; Shali Mazaki-Tovi; Tinnakorn Chaiworapongsa; John Hotra; Nandor Gabor Than; Jung-Sun Kim; Sonia S Hassan; Chong Jai Kim
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

2.  alpha2-macroglobulin modulates the immunoregulatory function of the lipocalin placental protein 14.

Authors:  G J Riely; J Rachmilewitz; P H Koo; M L Tykocinski
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 3.  The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited.

Authors:  Gary F Clark
Journal:  Mol Hum Reprod       Date:  2013-09-15       Impact factor: 4.025

4.  Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin-stimulated lymphocytes.

Authors:  A G Pockley; A E Bolton
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

5.  Immunomodulatory activity of glycodelin: implications in allograft rejection.

Authors:  A Dixit; B Balakrishnan; A A Karande
Journal:  Clin Exp Immunol       Date:  2018-01-18       Impact factor: 4.330

Review 6.  Placental Origins of Chronic Disease.

Authors:  Graham J Burton; Abigail L Fowden; Kent L Thornburg
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

7.  Serum PP12, PP14, SP1 and hCG values in the 28 days after the LH-surge in patients who do and do not conceive after artificial insemination or in vitro fertilization.

Authors:  G N Than; G Tatra; L Arnold; D G Szabó; I F Csaba; H Bohn
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

8.  Expression of glycodelin A in decidual tissue of preeclamptic, HELLP and intrauterine growth-restricted pregnancies.

Authors:  U Jeschke; C Kunert-Keil; I Mylonas; A Hammer; B Schiessl; I Lomba; C Kuhn; S Schulze; K Friese
Journal:  Virchows Arch       Date:  2005-03-09       Impact factor: 4.064

9.  Concentration of placental protein 19 in body fluid and placental tissues.

Authors:  M Takayama; K Isaka; Y Suzuki; H Funayama; Y Suzuki; K Akiya; H Bohn
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

10.  Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage.

Authors:  D M Morrow; N Xiong; R R Getty; M Z Ratajczak; D Morgan; M Seppala; L Riittinen; A M Gewirtz; M L Tykocinski
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.